Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Gedeon Richter Plc., Gyömrői út 19-21., 1103 Budapest, Hungary
Lenzetto 1.53 mg/spray, transdermal spray, solution.
| Pharmaceutical Form |
|---|
|
Transdermal spray, solution. The solution is clear, colourless to pale yellow. |
Each spray delivers 90 microliter of transdermal spray, solution containing 1.53 mg of estradiol (equivalent to 1.58 mg of estradiol hemihydrate).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Estradiol |
Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. |
| List of Excipients |
|---|
|
Octisalate |
The solution is packaged in a glass vial fitted with a metered dose pump. The unit is encased in a plastic housing with a conical bell opening that controls the distance, angle, and area of application of the metered dose spray.
One container is filled with 6,5 ml, transdermal spray solution and is designed to deliver 56 sprays after priming.
Pack sizes:
One plastic container 6,5 ml (56 sprays)
Three plastic containers 3x6,5 ml (3x56 sprays)
Not all pack sizes may be marketed.
Gedeon Richter Plc., Gyömrői út 19-21., 1103 Budapest, Hungary
PL 04854/0130
13/08/2015
| Drug | Countries | |
|---|---|---|
| LENZETTO | Ecuador, Estonia, Spain, Finland, Croatia, Ireland, Lithuania, Malta, Netherlands, Poland, Romania, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
